Dimitrios Gazgalis
0009-0002-2762-6989
2 papers found
Refreshing results…
De novo design of drug-binding proteins with predictable binding energy and specificity
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors
Missing publications? Search for publications with a matching author name.